Login / Signup
Amber Berning
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 3
Top Topics
Rna Seq
Gene Expression
Germ Cell
High Grade
Top Venues
Molecular cancer research : MCR
Molecular cancer therapeutics
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Brooke E Sanders
,
Tomomi M Yamamoto
,
Alexandra McMellen
,
Elizabeth R Woodruff
,
Amber Berning
,
Miriam D Post
,
Benjamin G Bitler
Targeting DUSP Activity as a Treatment for High-Grade Serous Ovarian Carcinoma.
Molecular cancer therapeutics
21 (8) (2022)
Alexandra McMellen
,
Tomomi M Yamamoto
,
Lubna Qamar
,
Brooke E Sanders
,
Lily L Nguyen
,
Daniela Ortiz Chavez
,
Jaidev Bapat
,
Amber Berning
,
Miriam D Post
,
Joshua Johnson
,
Kian Behbakht
,
Elmar Nurmemmedov
,
Edward Boyi Chuong
,
Benjamin G Bitler
ATF6-mediated signaling contributes to PARP Inhibitor Resistance in Ovarian Cancer.
Molecular cancer research : MCR
(2022)
Katie C Hall
,
Miriam D Post
,
Jill Alldredge
,
Dara L Aisner
,
Amber Berning
Molecular Evidence for Epithelial Origin of Mixed Ovarian Epithelial-Germ Cell Neoplasms: Report of 2 Cases and Review of Literature.
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists
(2022)